Regulatory issues in Europe

被引：8

|

作者：

Barbui, C ^{[1
]}

Guaiana, G ^{[1
]}

Garatini, S ^{[1
]}

机构：

[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2001年 / 21卷 / 06期

关键词：

D O I：

10.1097/00004714-200112000-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：545 / 548

页数：4

相关论文

共 50 条

[41] The Internet and international regulatory issues
Koomen, K
INTERNATIONAL INFORMATION & LIBRARY REVIEW, 1997, 29 (3-4) : 271 - 297
[42] Regulatory issues for influenza vaccines
Levandowski, R
Robertson, JS
Wood, JM
OPTIONS FOR THE CONTROL OF INFLUENZA III, 1996, 1123 : 844 - 846
[43] Regulatory issues and economic efficiency
Suarez-Almazor, ME
Drummond, M
JOURNAL OF RHEUMATOLOGY, 2003, 30 : 5 - 7
[44] Regulatory issues in severe dementia
Brassart, L
Saint Raymond, A
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S133 - S134
[45] Regulatory issues for biological pesticides
Dewhurst, Ian C.
TOXICOLOGY LETTERS, 2006, 164 : S39 - S40
[46] European regulatory issues in nanomedicine
Guerra G.
NanoEthics, 2008, 2 (1) : 87 - 97
[47] REGULATORY ISSUES ON ASPARTAME - NUTRASWEET
PHELPS, JR
ASSOCIATION OF FOOD & DRUG OFFICIALS QUARTERLY BULLETIN, 1986, 50 (02): : 96 - 101
[48] Regulatory Issues Surrounding Nanoparticles
Rice, P.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2009, 50 (07) : 555 - 555
[49] Regulatory issues in cellular therapies
Gee, AP
EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (04) : 537 - 540
[50] Selected supervisory and regulatory issues
Servenay, C
OECD PRIVATE PENSIONS CONFERENCE 2000, 2001, (03): : 247 - 253

← 1 2 3 4 5 →